1 min read
Latin America and the Caribbean (LAC) region is one of the world’s top emerging markets. Mexico, a part of the LAC, is full of opportunities, and expanding in Mexico can prove to be a game changer for global pharma manufacturers.
Mexico - The Land of Immense Opportunities
While the population in Mexico is growing at a rate of 1.09% per year, a major part of it consists of elderly citizens. The citizens are also experiencing an epidemiological transition from communicable diseases to chronic degenerative diseases. The country is also growing in terms of GDP purchase power parity, GDP real growth rate, and GDP per capita.
A strong financial foundation in a large fraction of the Mexican population, increasing health issues, and a requirement for quality medicines make Mexico a pharmaceutical manufacturer’s paradise.
S.W.O.T Analysis
At Freyr, we believe that every challenge can be converted into an opportunity with the right strategy, smart work, and effort. Be it the language barrier or local representation, Freyr is your one-stop solution for end-to-end Regulatory services. With our office establishment in Mexico, we are ready to build long-lasting partnerships with our clients.
Our team of seasoned Regulatory experts can provide Regulatory support in Regulatory Affairs, Market Access & Regulatory Strategy, Publishing & Submissions, Regulatory Labeling, Artwork Pack Management, Regulatory Medical Writing, Compliance & Validation services, Regulatory Software, and Pharmacovigilance.
For more information, check our website.
